Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Richard A C Hughes, Peter Donofrio, Vera Bril, Marinos C. Dalakas, Chunqin Deng, Kim Hanna, Hans Peter Hartung, Norman Latov, Ingemar S J Merkies, Pieter A. van Doorn, S. Apostolski, I. Basta, V. Divac, S. Pavlovic, R. Trikic, V. Drory, I. Artamonov, G. Groozman, M. Zielinska, W. FryzeJ. Swiatkiewicz, C. Munch, R. Reisin, A. M. Pardal, C. Marchesoni, J. Chapman, L. Benedetti, E. Ghiglione, M. Grandis, E. Narciso, A. Schenone, Z. Stelmasiak, H. Bartosik-Psujek, E. Belniak, U. Chyrchel, M. Kaminski, M. Banach, A. Bogucki, A. Pozdzik-Koseda, I. Szadkowska, A. Dubrovsky, E. Fulgenzi, A. Lautre, J. Bednarik, P. Dacci, U. del Carro, R. Fazio, M. Malaguti, N. Riva, F. P. Thomas, S. Nations, J. Trivedi, G. Wolfe, H. Patwa, B. Tsao, S. Cho, S. Oh, M. Morgan

Research output: Contribution to journal › Article › peer-review

549 Scopus citations

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Fingerprint

Medicine & Life Sciences